YOLFTbeta
60

Zhejiang Shapuaisi Pharmaceutical Co Ltd

603168 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

5.19CNY-0.03 (-0.57%)

Price History

Full chart

Market Stats

Previous Close5.22
Open5.26
Day Range5.14 – 5.30
52-Week Range4.55 – 8.81
Volume5.93M
Market Cap2.25B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.65
Dividend Yield0.00%
Beta0.14
50-Day Avg5.61
200-Day Avg6.36

About

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. It also offers medical and health care, and scientific research and teaching facilities. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Hong Li Lin
  • Employees1.14K
  • HeadquartersNo. 1588 Xinming Road, Pinghu, China, 314200, China
  • Websitehttps://www.zjspas.com

Leadership

  • Mr. Hong Li LinGM & Chairman · b. 1993
  • Mr. Xiusong LinDeputy GM, Financial Director, Director & Accounting Supervisor · b. 1969
  • Mr. Mingxiong HuangBoard Secretary & Director · b. 1993
  • Mr. Hong Sheng XuDeputy General Manager · b. 1982

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue146.52M174.54M272.55M408.68M544.76M628.14M765.58M921.67M978.73M938.88M607.44M515.96M346.81M629.76M549.54M644.97M483.96M462.78M
Growth (%)-+19.12%+56.16%+49.95%+33.30%+15.31%+21.88%+20.39%+6.19%-4.07%-35.30%-15.06%-32.78%+81.59%-12.74%+17.37%-24.96%-4.38%
Cost of Revenue87.05M89.19M110.33M137.54M181.55M194.40M225.08M245.34M231.19M215.34M178.50M195.07M157.97M232.59M233.57M288.12M252.67M250.08M
Gross Profit59.46M85.35M162.22M271.14M363.21M433.74M540.50M676.33M747.54M723.54M428.94M320.88M188.84M397.18M315.97M356.85M231.29M212.70M
Gross Margin40.59%48.90%59.52%66.34%66.67%69.05%70.60%73.38%76.38%77.06%70.61%62.19%54.45%63.07%57.50%55.33%47.79%45.96%
Operating Expense38.57M63.45M112.01M193.89M257.91M315.14M392.57M470.54M513.22M545.44M559.20M332.26M388.24M342.26M260.34M334.81M343.22M218.79M
Operating Income20.89M21.90M50.21M77.25M105.29M118.60M147.93M205.79M234.33M178.10M-130.26M-11.38M-199.40M54.92M55.62M22.04M-111.93M-6.09M
Operating Margin14.26%12.55%18.42%18.90%19.33%18.88%19.32%22.33%23.94%18.97%-21.44%-2.20%-57.50%8.72%10.12%3.42%-23.13%-1.32%
EBITDA32.44M34.27M62.82M104.27M119.13M139.08M183.31M236.24M369.42M236.90M-57.67M72.91M13.12M106.48M114.01M100.18M-43.13M-161.34M
EBITDA Margin22.14%19.64%23.05%25.51%21.87%22.14%23.94%25.63%37.74%25.23%-9.49%14.13%3.78%16.91%20.75%15.53%-8.91%-34.86%
Net Income18.06M19.08M43.10M67.91M90.89M104.08M131.27M176.04M275.72M146.36M-126.47M7.86M-179.37M35.66M44.75M25.41M-123.44M-238.72M
Net Income Margin12.32%10.93%15.81%16.62%16.68%16.57%17.15%19.10%28.17%15.59%-20.82%1.52%-51.72%5.66%8.14%3.94%-25.51%-51.58%
R&D---13.57M18.34M22.34M27.98M31.21M29.02M29.23M26.56M26.99M27.80M102.21M59.61M64.45M57.58M25.20M
R&D as % of Total Revenue---3.32%3.37%3.56%3.65%3.39%2.97%3.11%4.37%5.23%8.02%16.23%10.85%9.99%11.90%5.44%
Interest Expense3.13M2.80M2.64M4.44M5.82M5.69M6.00M108.87K5.79M40.99K1.18M34.03K188.54K2.12M2.75M6.01M8.53M7.94M
Interest Expense % of Total Revenue2.14%1.61%0.97%1.09%1.07%0.91%0.78%0.01%0.59%0.00%0.19%0.01%0.05%0.34%0.50%0.93%1.76%1.72%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets162.82M186.82M222.49M327.38M516.54M597.57M872.34M1.27B1.84B1.87B1.65B1.59B1.67B1.59B1.96B2.17B2.11B1.87B
Total Liabilities69.24M77.15M70.45M125.43M242.33M244.26M109.44M383.37M247.88M212.13M167.41M100.28M366.78M232.89M240.99M440.92M516.59M521.04M
Total Equity93.58M109.67M152.04M201.95M274.21M353.31M762.90M891.62M1.59B1.66B1.48B1.49B1.31B1.35B1.71B1.72B1.59B1.35B
Cash7.10M22.73M26.14M33.46M91.76M105.68M182.85M167.64M484.87M438.41M145.16M223.49M106.78M138.52M525.06M355.67M82.79M112.18M
Total Debt43.50M44.50M41.00M85.00M176.90M180.00M-50.00M----8.04M37.61M39.69M156.73M242.18M-
Net Debt36.40M21.77M14.86M51.54M85.14M74.32M-182.85M-117.64M-484.87M-438.41M-145.16M-223.49M-98.74M-100.91M-485.37M-198.93M159.40M146.00M

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow11.20M28.87M17.57M15.14M67.27M117.86M147.99M114.27M294.33M45.57M100.37M59.47M44.09M100.78M115.72M41.49M25.67M44.93M
Investing Cash Flow-12.97M-8.25M-7.97M-29.48M-73.69M-71.20M-162.87M-132.16M-248.21M-8.72M-343.99M18.86M-157.25M142.28M-44.45M-345.89M-335.66M-
Financing Cash Flow2.74M-4.61M-6.19M21.66M64.72M-32.74M92.04M2.69M271.10M-83.31M-49.63M-3.55M-3.55M-211.32M315.26M135.01M37.11M-
Capital Expenditure13.01M8.49M8.06M29.59M71.91M71.73M102.53M97.94M39.94M114.00M58.38M20.33M17.18M153.44M148.69M219.80M128.11M94.15M
Free Cash Flow-1.82M20.39M9.51M-14.45M-4.64M46.13M45.46M16.34M254.39M-68.42M42.00M39.14M26.91M-52.66M-32.97M-178.30M-102.43M-49.22M
Dividends Paid5.26M5.61M2.69M22.34M27.18M35.84M34.70M47.31M59.71M83.31M49.63M3.55M3.55M--13.77M14.53M7.94M
FCF to OCF-16.22%70.61%54.13%-95.42%-6.90%39.14%30.72%14.30%86.43%-150.14%41.84%65.81%61.04%-52.25%-28.49%-429.71%-399.01%-109.56%
Dividend Paid to FCF-289.84%27.51%28.24%-154.62%-585.72%77.69%76.33%289.63%23.47%-121.75%118.17%9.07%13.19%---7.72%-14.18%-16.13%

Earnings

Report DateOct 27, 2014Dec 31, 2014Apr 28, 2015Aug 22, 2015Oct 27, 2015Mar 31, 2016Apr 1, 2016Aug 23, 2016Oct 27, 2016Dec 31, 2016Apr 25, 2017Aug 18, 2017Oct 26, 2017Dec 31, 2017Apr 25, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 21, 2020Oct 29, 2020Mar 30, 2021Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----------------------------------
EPS Actual0.120.110.140.140.140.160.180.180.350.210.160.100.180.020.130.030.08-0.630.060.020.04-0.100.00-0.05-0.04-0.470.030.050.03-0.000.090.020.030.000.06
Surprise-----------------------------------
TimingAfter-hours-Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-market-After-hoursPre-marketAfter-hours-Pre-market--------------------

Key Statistics & Ratios

Market Cap2.25B
Enterprise Value2.27B
Trailing P/E0.00
Forward P/E0.00
Price / Sales5.32
Price / Book1.60
EPS-0.65
Book Value3.66
Revenue (TTM)423.20M
Gross Profit (TTM)156.87M
EBITDA-22.49M
Profit Margin-56.97%
Operating Margin-22.63%
Return on Equity-16.16%
Return on Assets-2.68%
Shares Outstanding372.51M
Shares Float206.93M
Beta0.14
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.04Jun 9, 2023
20201×
0.01Jun 12, 2020
20181×
0.20Jun 8, 2018
20171×
0.36Jun 8, 2017
20161×
0.18May 13, 2016
20151×
0.40Jun 9, 2015

Stock Splits

  • Jun 8, 201813:10
  • Jun 8, 2017188394:134567
  • Jun 9, 20155:2